WARBINGTON TIMOTHY (President & CEO) purchased 167.4% of their position (42K shares) of CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. on the open market
Open‑market purchase worth $24.8K — a major conviction buy. The strongest form of insider conviction signal.
P · 5 purchases
Filed: 9/22/2022ACC: 0001477932-22-007108
DirectorOfficer10% Owner· President & CEO
Since Oct 2018
+42K
Net shares
Net buyer
$24.8K
Total acquired
5
Open market trades
5B · 0S
5
Total transactions
42K acquired
Non-Derivative Transactions5
Common Stock
Direct
Shares
+5K
Price / share
$0.61
Trade value
$3.05K
% of position
19.9%
—
25.09K→30.09K
Common Stock
Direct
Shares
+4.50K
Price / share
$0.64
Trade value
$2.87K
% of position
15.0%
—
30.09K→34.59K
Common Stock
Direct
Shares
+500.00
Price / share
$0.63
Trade value
$314.00
% of position
1.4%
—
34.59K→35.09K
Common Stock
Direct
Shares
+20K
Price / share
$0.60
Trade value
$12.10K
% of position
57.0%
—
35.09K→55.09K
Common Stock
Direct
Shares
+12K
Price / share
$0.54
Trade value
$6.48K
% of position
21.8%
—
55.09K→67.09K
Total
Net shares
+42K
Net value
$24.82K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | — | P · Purchase | +5K | $0.61 | $3.05K | 19.9% | 25.09K | 30.09K |
| Common Stock Direct | — | P · Purchase | +4.50K | $0.64 | $2.87K | 15.0% | 30.09K | 34.59K |
| Common Stock Direct | — | P · Purchase | +500.00 | $0.63 | $314.00 | 1.4% | 34.59K | 35.09K |
| Common Stock Direct | — | P · Purchase | +20K | $0.60 | $12.10K | 57.0% | 35.09K | 55.09K |
| Common Stock Direct | — | P · Purchase | +12K | $0.54 | $6.48K | 21.8% | 55.09K | 67.09K |
| Total | +42K | $24.82K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned226.95K
Total
226.95K indirect226.95K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 226.95K | Indirect |
| Total | 226.95K | 226.95K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported